SOPHiA GENETICS Reports Strong Traction in the Launch Phase of its DEEP-Lung-IV Multimodal Clinical Study

Study leverages deep learning-enabled analysis of the aggregation of real-world multimodal data to validate predictive signatures associated with response to immunotherapy and prognosis of patients

Related Keywords

Germany ,Leipzig ,Sachsen ,Jerusalem ,Israel General ,Israel ,Paris ,France General ,France ,Boston ,Massachusetts ,United States ,Canada ,Toronto ,Ontario ,Switzerland ,Sunnybrook ,Alberta ,Jurgi Camblong ,Instagram ,Linkedin ,Twitter ,Leipzig University ,Sunnybrook Health Sciences Center ,Nasdaq ,Shaare Zedek Medical Center ,Carbone Comprehensive Cancer Center ,Holden Comprehensive Cancer Center ,Iowa Health Care ,Assistance Publique H ,Hospices Civils De Lyon ,Chief Executive Officer ,Looking Statements ,Sophia ,Enetics ,Reports ,Strong ,Fraction ,Launch ,Hase ,Jeep ,Young ,Multimodal ,Linical ,Study ,